HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Chronic hepatitis e in heart transplant recipients.

Abstract
Chronic courses of hepatitis E virus (HEV) infections have been described in immunosuppressed patients. We aimed to study the role of HEV infections in heart transplant recipients (HTR). 274 HTR were prospectively screened for HEV infection using an anti-HEV-IgG ELISA and HEV-PCR. In addition, 137 patients undergoing cardiac surgery (non-HTR) and 537 healthy subjects were studied cross-sectionally. The anti-HEV-IgG seroprevalence was 11% in HTR, 7% in non-HTR and 2% in healthy controls (HTR vs. healthy controls p<0.0001; non-HTR vs. healthy controls p<0.01). Anti-HEV tested positive in 4.0% in control cohorts of other immunocompromised patients (n = 474). Four HTR (1.5%) were chronically infected with HEV as shown by HEV-PCR and all four patients had liver transaminases of >200 IU/L and histological or clinical evidence of advanced liver disease. In three patients ribavirin treatment was successful with a sustained biochemical and virological response while treatment failed in one cirrhotic patient after ribavirin dose reduction. Heart transplant recipients and patients undergoing cardiac surgery have an increased risk for HEV infections. Chronic hepatitis E may explain elevated liver enzymes in heart transplant recipients. Treatment of HEV infection with ribavirin is effective but the optimal dose and duration of ribavirin therapy remains to be determined.
AuthorsS Pischke, P Stiefel, B Franz, B Bremer, P V Suneetha, A Heim, T Ganzenmueller, J Schlue, R Horn-Wichmann, R Raupach, M Darnedde, Y Scheibner, R Taubert, A Haverich, M P Manns, H Wedemeyer, C L Bara
JournalAmerican journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (Am J Transplant) Vol. 12 Issue 11 Pg. 3128-33 (Nov 2012) ISSN: 1600-6143 [Electronic] United States
PMID22823202 (Publication Type: Comparative Study, Journal Article, Research Support, Non-U.S. Gov't)
Copyright© Copyright 2012 The American Society of Transplantation and the American Society of Transplant Surgeons.
Chemical References
  • Hepatitis Antibodies
  • RNA, Viral
Topics
  • Adolescent
  • Adult
  • Age Distribution
  • Aged
  • Aged, 80 and over
  • Biopsy, Needle
  • Case-Control Studies
  • Chronic Disease
  • Enzyme-Linked Immunosorbent Assay
  • Female
  • Follow-Up Studies
  • Germany (epidemiology)
  • Heart Transplantation (immunology, statistics & numerical data)
  • Hepatitis Antibodies (analysis)
  • Hepatitis E (epidemiology, immunology, pathology)
  • Hepatitis E virus (immunology, isolation & purification)
  • Humans
  • Immunocompromised Host (immunology)
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Polymerase Chain Reaction
  • Prevalence
  • Prospective Studies
  • RNA, Viral (analysis)
  • Risk Assessment
  • Sex Distribution
  • Statistics, Nonparametric
  • Survival Rate
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: